Media Centre
Latest press releases
-
Update on the DARE-19 Phase III trial for Farxiga in COVID-19
-
AstraZeneca accelerates early oncology pipeline across key strategic scientific platforms at AACR
-
AZD1222 US Phase III primary analysis confirms safety and efficacy
-
Statement on COVID-19 vaccine supply at Anagni plant in Italy
-
Update following statement by NIAID on AZD1222 US Phase III trial data
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Email the Global Media Relations team at:
Gonzalo Viña
Head of Global Media Relations
+44 (0)1223 344 800
Kim Blomley
Director Global Media Relations (Oncology)
+44 (0)1223 344 800
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 (0)1223 344 800
Fiona Cookson
Director Global Media Relations (Covid-19)
+44 (0)1223 344 800
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
